Development of Radiolabeled Compounds for Myocardial Perfusion Imaging

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|8|1041-1057

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.8, 2012-03, pp. : 1041-1057

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radiolabeled Compounds in the Development of Cytotoxic Agents

By  

Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. : 2923-2934

Bentham Science Publishers

Access to resources Recommend Favorite

The Use of Radiolabeled Compounds for ADME Studies in Discovery and Exploratory Development

By  

Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. : 2991-3008

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot Topic: Radiolabeled Compounds for Drug Discovery and Development (Executive Editor: Antti Jekunen)]

By  

Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. : i-ii

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot Topic: Radiolabeled Compounds for Drug Discovery and Development (Executive Editor: Antti Jekunen)]

By  

Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. : ii-ii

Bentham Science Publishers

Access to resources Recommend Favorite

Imaging Drug Resistance with Radiolabeled Molecules

By  

Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. : 2965-2979

Bentham Science Publishers

Access to resources Recommend Favorite